{"schema_version":"1","generated_at":"2026-11-09T15:24:03.170Z","data_as_of":null,"url":"https://www.findmykol.com/kol/anita-sircar","json_url":"https://www.findmykol.com/kol/anita-sircar/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"anita-sircar","name":"Anita Sircar","credential":"MD","specialty":"Infectious Disease","specialty_raw":"Infectious Disease","therapeutic_area":"Infectious Disease","therapeutic_areas":["Infectious Disease"],"city":"Torrance","state":"CA","region":{"label":"West","url":"https://www.findmykol.com/region/west"}},"identifiers":{"npi":"1851553960","openalex":"A5021040836"},"summary":"Anita Sircar is an Infectious Disease physician. OpenAlex indexes 9 publications with 205 citations (h-index 5).","overview":null,"focus":{"indications":[],"research_topics":["Infectious Disease"]},"scholarship":{"works_count":9,"cited_by_count":205,"h_index":5,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":1,"program_years":{"first":2021,"last":null},"rows_total":1,"shown":1,"withheld":0,"rows":[{"payer":"Astellas Pharma US Inc","program_year":2021,"amount_usd":35.89,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1851553960"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1851553960","source":"payments"},"prescribing":{"data_year":2022,"areas_total":1,"areas_shown":1,"areas":[{"area":"Anti-infectives","share_pct":100,"classes_total":2,"classes":[{"class":"Macrolide Antimicrobial","setting":"prescribed","share_pct":50,"drugs":[{"name":"Azithromycin","share_pct":100}],"max_beneficiaries":null},{"class":"Rifamycin Antibacterial","setting":"prescribed","share_pct":50,"drugs":[{"name":"Rifampin","share_pct":100}],"max_beneficiaries":null}]}],"care_setting":{"dominant":"facility","data_year":2022,"office_pct":1.3,"facility_pct":98.7},"source":"medicare"},"publications":{"total":9,"shown":5,"withheld":4,"matched_by":"OpenAlex author record","recent":[{"title":"Successful Treatment of an Atypical Mycobacterial Exit Site Infection in a Patient on Peritoneal Dialysis: A Case Report","year":2026,"journal":"Cureus","source_url":"https://doi.org/10.7759/cureus.116233","status":"verified"},{"title":"Disseminated histoplasmosis in an immunosuppressed patient successfully treated with isavuconazole","year":2023,"journal":"BMJ Case Reports","source_url":"https://doi.org/10.1136/bcr-2022-253718","status":"verified"},{"title":"Safety and efficacy of co-administered diethylcarbamazine, albendazole and ivermectin during mass drug administration for lymphatic filariasis in Haiti: Results from a two-armed, open-label, cluster-randomized, community study","year":2020,"journal":"PLoS neglected tropical diseases","source_url":"https://doi.org/10.1371/journal.pntd.0008298","status":"verified"},{"title":"Investigation of Dracunculiasis Transmission among Humans, Chad, 2013–2017","year":2020,"journal":"American Journal of Tropical Medicine and Hygiene","source_url":"https://doi.org/10.4269/ajtmh.20-0584","status":"verified"},{"title":"The safety of double- and triple-drug community mass drug administration for lymphatic filariasis: A multicenter, open-label, cluster-randomized study","year":2019,"journal":"PLoS Medicine","source_url":"https://doi.org/10.1371/journal.pmed.1002839","status":"verified"}],"source":"works"},"contact":{"address_1":"3701 SKYPARK DR STE 200","city":"Torrance","state":"CA","zip":"905054749","phone":"310-378-8900","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1851553960","source":"identity"},"similar":[{"name":"Thomas Walsh","slug":"thomas-walsh","institution":"Cornell University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/thomas-walsh","json_url":"https://www.findmykol.com/kol/thomas-walsh/profile.json"},{"name":"Douglas Richman","slug":"douglas-richman","institution":"University of California San Diego","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/douglas-richman","json_url":"https://www.findmykol.com/kol/douglas-richman/profile.json"},{"name":"Henry Masur","slug":"henry-masur","institution":"National Institutes of Health","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/henry-masur","json_url":"https://www.findmykol.com/kol/henry-masur/profile.json"},{"name":"Vance Fowler","slug":"vance-fowler","institution":"Duke University","specialty":"Infectious Disease","url":"https://www.findmykol.com/kol/vance-fowler","json_url":"https://www.findmykol.com/kol/vance-fowler/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"publications":4}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2024-04-30","provider_certified":"2024-04-30","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2022}},"methodology_url":"https://www.findmykol.com/about#methodology"}